Ysios Capital

Ysios Capital is a prominent European venture capital firm headquartered in San Sebastian, Spain, with a dedicated focus on the life sciences sector. Established as a leading investor, the firm primarily targets highly innovative companies globally, specializing in areas such as therapeutics, medical devices, and diagnostics. Their investment philosophy centers on identifying and nurturing groundbreaking scientific advancements that address significant unmet medical needs, aiming to translate cutting-edge research into tangible healthcare solutions.

The firm employs a comprehensive investment strategy, typically engaging with companies from early-stage development through to growth stages. Ysios Capital is known for its hands-on approach, providing not only capital but also strategic guidance, operational support, and access to a broad network of industry experts. This collaborative model is designed to accelerate the development and commercialization of their portfolio companies' technologies, ensuring they are well-positioned for success in the competitive global life sciences market.

Ysios Capital has successfully raised multiple funds, demonstrating a strong track record and investor confidence. Their latest fund, Ysios BioFund III, closed in 2023 with a substantial €194 million, significantly bolstering their capacity to invest in promising life science ventures. Across all its funds, Ysios Capital manages assets exceeding €380 million, solidifying its position as a major player in the European biotech investment landscape. The firm's initial investments typically range from €3 million to €10 million, with the potential for follow-on investments that can bring the total commitment per company up to €20 million over the investment lifecycle. This flexible investment approach allows them to support companies through various critical development milestones.